Alireza Gheflati

Alireza Gheflati

Auto-generated profile, based on publicly available information

Alireza Gheflati

Nutrition and Food Health Research Center AJA University of Medical Sciences Tehran Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Complementary Therapies in Clinical Practice
Verified
Journal Article
Closed access
ASAfsaneh Salari
Afsaneh Salari
SGSara Ghodrat
Sara Ghodrat
AGAlireza Gheflati
Alireza Gheflati
LJLida Jarahi
Lida Jarahi
MHMohammad Hashemi
Mohammad Hashemi
AAAsma Afshari
Asma Afshari

6 October 2024 in Health Science Reports
Verified
Journal Article
Open access
MJMostafa Shahraki Jazinaki
Mostafa Shahraki Jazinaki
AGAlireza Gheflati
Alireza Gheflati
MMMohammad Reza Shadmand Foumani Moghadam
Mohammad Reza Shadmand Foumani Moghadam
SHSaeid Hadi
Saeid Hadi
MRMaryam Razavidarmian
Maryam Razavidarmian
MSMohammadq Safarian
Mohammadq Safarian
Background and Aims: Alternative therapies, such as zinc supplementation, have been explored as potential interventions for sleep disorders. However, the efficacy of zinc supplementation in improving sleep quality remains uncertain. This systematic review aims to examine the impacts of zinc supplementation on sleep quality in humans.Methods: The Web of Science, Medline, Scopus, and Google Scholar databases were comprehensively searched to find studies investigating the effect of zinc supplementation on sleep quality. After identifying relevant studies by screening, relevant data were extracted from them. The quality assessment was conducted using the Cochrane quality assessment tool.Results: This systematic review included eight studies. The interventions ranged from 4 to 48 weeks, with a daily dose of zinc supplementation varying between 10 and 73.3 mg. The majority of the evidence examined in this review pointed to the significant improvement effect of zinc supplementation on sleep quality in adults compared to the control groups. Furthermore, zinc supplementation did not have a significant effect on sleep disorders. However, there was no consensus about these findings. Also, the effect of supplementation on sleep duration in nonadults was contradictory.Conclusions: This systematic review suggests that zinc supplementation may lead to improvements in sleep quality. However, more research, primarily clinical trials, is needed to clarify the beneficial effects of zinc supplementation on sleep quality with consideration of dietary zinc intake and the Recommended Dietary Allowances of zinc (RDA) in the different populations. It is also recommended to investigate the effect of zinc supplementation on sleep quality in people with zinc deficiency in future studies.

1 January 2025 in Clinical Nutrition Research
Verified
Journal Article
Open access
PDF file
ZMZahra Moghaddas Mashhour
Zahra Moghaddas Mashhour
HBHanieh Barghchi
Hanieh Barghchi
AGAlireza Gheflati
Alireza Gheflati
AMAmir Hossein Mansouri
Amir Hossein Mansouri
ZDZahra Dehnavi
Zahra Dehnavi
ENElyas Nattagh
Elyas Nattagh
Mashhour ZM, et al. Clin Nutr Res. 2025 Jul;14(3):230-240. https://doi.org/10.7762/cnr.2025.14.3.230

29 July 2026 in Food Science & Nutrition
Verified
Journal Article
Open access
PDF file
AGAlireza Gheflati
Alireza Gheflati
MMMohammad Rashid Mayvan
Mohammad Rashid Mayvan
MAMojgan Mehri Ardestani
Mojgan Mehri Ardestani
SMSeyed Mahdi Mirghazanfari
Seyed Mahdi Mirghazanfari
EHEbrahim Hazrati
Ebrahim Hazrati
SHSaeid Hadi
Saeid Hadi
Traumatic brain injury (TBI) is the leading cause of death from injury. Many studies have shown that cytokines, chemokines, and oxidative stress play a crucial role in the pathophysiology of TBI. One of the types of interventions that are receiving more and more attention is nutritional support and the use of nutritional supplements to reduce inflammation in these patients. The present study was a double‐blind controlled clinical trial, performed on patients with traumatic brain injury. Patients in the intervention group received 600 mg of oral bromelain daily through gavage, while the patients in the control group received a placebo for 14 days. SOFA, APACHE, and NUTRIC scores were evaluated at each time of blood sampling and 28‐ and 60‐day mortality. Also, clinical and biochemical information (CRP, MDA, IL‐6, and TAC), anthropometry, and nutritional information of patients were recorded during the study. There was no significant difference between the two groups in terms of gender, weight, BMI, MAC, APACHE SCORE, NUTRIC SCORE, SOFA SCORE, and energy intake at the beginning of the study ( p > 0.05). Bromelain supplementation significantly reduced IL‐6 levels ( p < 0.001), APACHE score ( p = 0.011), SOFA score ( p < 0.001), and NUTRIC score ( p < 0.001). Furthermore, 60‐day mortality was significantly lower in the bromelain group compared to the placebo group ( p = 0.036). However, there was no significant effect on CRP ( p = 0.377), MDA ( p = 0.061), TAC levels ( p = 0.185). Bromelain supplementation significantly improved IL‐6 levels, APACHE, SOFA, and NUTRIC scores, and reduced 60‐day mortality in patients with traumatic brain injury. However, its effects on CRP, MDA and TAC levels were not statistically significant. These findings suggest that bromelain may serve as a promising adjunctive therapy to reduce inflammation and improve clinical outcomes in critically ill TBI patients. Further studies with larger sample sizes and longer follow‐up periods are needed to confirm these results.